OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases.

Through an extensive portfolio of high-performance stents and balloons, OrbusNeich provides proven solutions to interventional cardiologists worldwide.




OrbusNeich leads the way in pro-healing stent technology. COMBO™, the world’s first dual therapy stent accelerates endothelial coverage and controls neo-intimal proliferation through the combination of the Genous EPC capture technology with an abluminal sirolimus drug elution.
First patient enrollment in MASCOT registry represents major milestone for COMBO™ Dual T... READ MORE...

OrbusNeich Announces First Patient Enrollment in Physician-Initiated Study to Evaluate the Potential for Short... READ MORE...
Visit us at Asia Primary Angioplasty Congress 2014, Singapore, August 2-3 READ MORE...

Visit us at 8th Annual Australia & New Zealand Endovascular Therapies Meeting, Melbourne, Australia, August 20-22 READ MORE...